Helix 11 Dynamics is Critical for Constitutive Androstane Receptor Activity

Article, Other literature type English OPEN
Wright, Edward ; Busby, Scott A. ; Wisecarver, Sarah ; Vincent, Jeremy ; Griffin, Patrick R. ; Fernandez, Elias J. (2011)
  • Publisher: Elsevier BV
  • Journal: Structure, volume 19, issue 1, pages 37-44 (issn: 0969-2126)
  • Related identifiers: doi: 10.1016/j.str.2010.11.008
  • Subject: Molecular Biology | Structural Biology | Article
    mesheuropmc: human activities | body regions | embryonic structures | lipids (amino acids, peptides, and proteins) | hormones, hormone substitutes, and hormone antagonists

The constitutive androstane receptor (CAR) transactivation can occur in the absence of exogenous ligand and this activity is enhanced by agonists TCPOBOP and meclizine. We use biophysical and cell-based assays to show that increased activity of CAR(TCPOBOP) relative to CAR(meclizine) corresponds to a higher affinity of CAR(TCPOBOP) for the steroid receptor coactivator-1. Additionally, steady-state fluorescence spectra suggest conformational differences between CAR(TCPOBOP):RXR and CAR(meclizine):RXR. Hydrogen/deuterium exchange (HDX) data indicate that the CAR activation function 2 (AF-2) is more stable in CAR(TCPOBOP):RXR and CAR(meclizine):RXR than in CAR:RXR. HDX kinetics also show significant differences between CAR(TCPOBOP):RXR and CAR(meclizine):RXR. Unlike CAR(meclizine):RXR, CAR(TCPOBOP):RXR shows a higher overall stabilization that extends into RXR. We identify residues 339–345 in CAR as an allosteric regulatory site with a greater magnitude reduction in exchange kinetics in CAR(TCPOBOP):RXR than CAR(meclizine):RXR. Accordingly, assays with mutations on CAR at leucine-340 and leucine-343 confirm this region as an important determinant of CAR activity.
Share - Bookmark